Alvogen has an innate passion for performance and growth and has become a major player driving change in this ever-changing industry. Alvogen‘s passionate team is committed to continue growing the business around the world and build a leading generic pharmaceuticals player.
A unique portfolio of high-quality and difficult-to-make pharmaceutical products fuels their targeted growth strategy.
By 2025 this will have inspired Alvogen in becoming a leading global generic pharmaceutical company and a preferred partner that continuously provides a meaningful difference in the life of the people Alvogen serve.
“Our vision is to become the preferred partner by setting a new standard for the future of pharma.”
Róbert Wessman, CEO of Alvogen
The world is constantly changing all around us and the traditional generics models are being challenged. Alvogen is ready to move swiftly and react to a rapidly changing environment and tough competitors.
Alvogen is determined to become the preferred partner in all markets and have a clear vision on how they want the company to develop and grow, which is outlined in their strategic roadmap that outlines customer commitments: The Alvogen STARMAP.
The Alvogen STARMAP
We focus on building a well targeted and profitable portfolio in all our markets to serve our customers.
02 - Quality
We are committed to the highest quality standards for all our products and services.
03 - Service
We continuously focus on providing consistent and reliable high quality service to our customers.
04 - People
We focus on selecting and retaining the best talent in every field to fuel our success through our performance driven culture.
05 - Cost
We are a lean global organization with continuous focus on operational efficiency and cost.